FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308179251> ?p ?o ?g. }

• W4308179251 endingPage "164" @default.
• W4308179251 startingPage "155" @default.
• W4308179251 abstract "Alterations in hepatic transporters have been identified in precirrhotic chronic liver diseases (CLDs) that result in pharmacokinetic variations causing adverse drug reactions (ADRs). However, the effect of CLD on the expression of renal transporters is unknown despite the overwhelming evidence of kidney injury in CLD patients. This study determines the transcriptomic and proteomic expression profiles of renal drug transporters in patients with defined CLD etiology. Renal biopsies were obtained from patients with a history of CLD etiologies, including nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), alcohol-associated liver disease (ALD), viral hepatitis C (HCV), and combination ALD/HCV. A significant decrease in organic anion transporter (OAT)-3 was identified in NASH, ALD, HCV, and ALD/HCV (1.56 ± 1.10; 1.01 ± 0.46; 1.03 ± 0.43; 0.86 ± 0.57 pmol/mg protein) relative to control (2.77 ± 1.39 pmol/mg protein). Additionally, a decrease was shown for OAT4 in NASH (24.9 ± 5.69 pmol/mg protein) relative to control (43.8 ± 19.9 pmol/mg protein) and in urate transporter 1 (URAT1) for ALD and HCV (1.56 ± 0.15 and 1.65 ± 0.69 pmol/mg protein) relative to control (4.69 ± 4.59 pmol/mg protein). These decreases in organic anion transporter expression could result in increased and prolonged systemic exposure to drugs and possible toxicity. Renal transporter changes, in addition to hepatic transporter alterations, should be considered in dose adjustments for CLD patients for a more accurate disposition profile. It is important to consider a multiorgan approach to altered pharmacokinetics of drugs prescribed to CLD patients to prevent ADRs and improve patient outcomes. SIGNIFICANCE STATEMENT: Chronic liver diseases are known to elicit alterations in hepatic transporters that result in a disrupted pharmacokinetic profile for various drugs. However, it is unknown if there are alterations in renal transporters during chronic liver disease, despite strong indications of renal dysfunction associated with chronic liver disease. Identifying renal transporter expression changes in patients with chronic liver disease facilitates essential investigations on the multifaceted relationship between liver dysfunction and kidney physiology to offer dose adjustments and prevent adverse drug reactions." @default.
• W4308179251 created "2022-11-08" @default.
• W4308179251 creator A5007429759 @default.
• W4308179251 creator A5017318940 @default.
• W4308179251 creator A5019500582 @default.
• W4308179251 creator A5036022682 @default.
• W4308179251 creator A5041568284 @default.
• W4308179251 creator A5059488873 @default.
• W4308179251 creator A5069707022 @default.
• W4308179251 date "2022-11-03" @default.
• W4308179251 modified "2023-09-30" @default.
• W4308179251 title "Renal Transporter Alterations in Patients with Chronic Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination" @default.
• W4308179251 cites W1513603541 @default.
• W4308179251 cites W1601342866 @default.
• W4308179251 cites W1801619426 @default.
• W4308179251 cites W1969873315 @default.
• W4308179251 cites W2065570335 @default.
• W4308179251 cites W2067192749 @default.
• W4308179251 cites W2070466987 @default.
• W4308179251 cites W2108261774 @default.
• W4308179251 cites W2114622644 @default.
• W4308179251 cites W2124264125 @default.
• W4308179251 cites W2142591922 @default.
• W4308179251 cites W2146658664 @default.
• W4308179251 cites W2170989872 @default.
• W4308179251 cites W2504479633 @default.
• W4308179251 cites W2515541303 @default.
• W4308179251 cites W2561783875 @default.
• W4308179251 cites W2586590687 @default.
• W4308179251 cites W2796471395 @default.
• W4308179251 cites W2804552830 @default.
• W4308179251 cites W2897450526 @default.
• W4308179251 cites W2903455993 @default.
• W4308179251 cites W2968470226 @default.
• W4308179251 cites W2973580251 @default.
• W4308179251 cites W2980570124 @default.
• W4308179251 cites W3047531688 @default.
• W4308179251 cites W3048245687 @default.
• W4308179251 cites W3093171260 @default.
• W4308179251 cites W3166771520 @default.
• W4308179251 cites W4200187233 @default.
• W4308179251 cites W4283815202 @default.
• W4308179251 doi "https://doi.org/10.1124/dmd.122.001038" @default.
• W4308179251 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36328481" @default.
• W4308179251 hasPublicationYear "2022" @default.
• W4308179251 type Work @default.
• W4308179251 citedByCount "2" @default.
• W4308179251 countsByYear W43081792512023 @default.
• W4308179251 crossrefType "journal-article" @default.
• W4308179251 hasAuthorship W4308179251A5007429759 @default.
• W4308179251 hasAuthorship W4308179251A5017318940 @default.
• W4308179251 hasAuthorship W4308179251A5019500582 @default.
• W4308179251 hasAuthorship W4308179251A5036022682 @default.
• W4308179251 hasAuthorship W4308179251A5041568284 @default.
• W4308179251 hasAuthorship W4308179251A5059488873 @default.
• W4308179251 hasAuthorship W4308179251A5069707022 @default.
• W4308179251 hasConcept C104317684 @default.
• W4308179251 hasConcept C123584848 @default.
• W4308179251 hasConcept C126322002 @default.
• W4308179251 hasConcept C134018914 @default.
• W4308179251 hasConcept C149011108 @default.
• W4308179251 hasConcept C2776455275 @default.
• W4308179251 hasConcept C2776954865 @default.
• W4308179251 hasConcept C2777075537 @default.
• W4308179251 hasConcept C2777214474 @default.
• W4308179251 hasConcept C2777575235 @default.
• W4308179251 hasConcept C2778772119 @default.
• W4308179251 hasConcept C2779134260 @default.
• W4308179251 hasConcept C2780091579 @default.
• W4308179251 hasConcept C55493867 @default.
• W4308179251 hasConcept C71924100 @default.
• W4308179251 hasConcept C86803240 @default.
• W4308179251 hasConcept C98274493 @default.
• W4308179251 hasConceptScore W4308179251C104317684 @default.
• W4308179251 hasConceptScore W4308179251C123584848 @default.
• W4308179251 hasConceptScore W4308179251C126322002 @default.
• W4308179251 hasConceptScore W4308179251C134018914 @default.
• W4308179251 hasConceptScore W4308179251C149011108 @default.
• W4308179251 hasConceptScore W4308179251C2776455275 @default.
• W4308179251 hasConceptScore W4308179251C2776954865 @default.
• W4308179251 hasConceptScore W4308179251C2777075537 @default.
• W4308179251 hasConceptScore W4308179251C2777214474 @default.
• W4308179251 hasConceptScore W4308179251C2777575235 @default.
• W4308179251 hasConceptScore W4308179251C2778772119 @default.
• W4308179251 hasConceptScore W4308179251C2779134260 @default.
• W4308179251 hasConceptScore W4308179251C2780091579 @default.
• W4308179251 hasConceptScore W4308179251C55493867 @default.
• W4308179251 hasConceptScore W4308179251C71924100 @default.
• W4308179251 hasConceptScore W4308179251C86803240 @default.
• W4308179251 hasConceptScore W4308179251C98274493 @default.
• W4308179251 hasIssue "2" @default.
• W4308179251 hasLocation W43081792511 @default.
• W4308179251 hasLocation W43081792512 @default.
• W4308179251 hasOpenAccess W4308179251 @default.
• W4308179251 hasPrimaryLocation W43081792511 @default.
• W4308179251 hasRelatedWork W1973843004 @default.
• W4308179251 hasRelatedWork W2042033030 @default.
• W4308179251 hasRelatedWork W2127085070 @default.

• next